Document is current

Article History

Received: 19 July 2024

Accepted: 1 October 2024

First Online: 23 October 2024

Declarations

:

: Rahul H. Dave has received honoraria for speaking engagements and consulting activities from Biogen, Bristol Myers Squibb, EMD Serono, Genentech, Novartis, Sanofi, and TG Therapeutics and has also received honoraria for the provision of clinical trial support to EMD Serono, Inova, and Novartis. Heidi Crayton has served as a consultant for Biogen, Bristol Myers Squibb, EMD Serono, and Sanofi Genzyme; has received research support from Biogen, EMD Serono, Novartis, Roche/Genentech, and Sanofi Genzyme. Augusto Miravalle has received honoraria for consulting activities, research grants, and speaker fees from Alexion, Biogen, Bristol Myers Squibb, EMD Serono, Genentech, Novartis, Sanofi Genzyme, and TG Therapeutics. Ming-Hui Tai and Kerri Wyse are employees and stockholders of Novartis Pharmaceuticals Corporation. Katherine Houghton and Abby Hitchens are salaried employees of RTI Health Solutions, a research organization that provides consulting services to pharmaceutical companies; they did not receive compensation for participating in this work and do not have any other conflicts of interest. Regina Berkovich has received honoraria for speaking engagements, serving on scientific advisory boards, and consulting activities from Alexion, Amgen, ANI Pharmaceuticals, Biogen, EMD Serono, Mallinckrodt Pharmaceuticals, Novartis, Sanofi, and TG Therapeutics.

: On November 2, 2021, WCG IRB approved a request for a waiver of authorization for use and disclosure of protected health information (PHI) under 45 CFR 46 116(f) [2018 Requirements] 45 CFR 46.116(d) [Pre-2018 Requirements]. This review was conducted through expedited review.